Target Arm Announces Eric Achtmann to Join Board of Directors

RIDGEFIELD, Conn. - Feb. 9, 2021 - PRLog -- Target Arm Inc. is proud to announce that Eric Achtmann has joined our Board of Directors as of January 29, 2020 for a two-year term. Target Arm's Board of Directors is poised to lead the company into the emerging drone industry as the US national airspace begins to open up in 2021 and beyond.

CEO & Founder, Jeffrey McChesney was elated to have Eric join the Board and said, "Eric is a tremendous addition to our Board and brings passion, deep technical and financial expertise, as well as an extremely pragmatic way of viewing business. As we unveil our fully electric solutions, the future of autonomy is very bright with Eric's deep knowledge of EVs and product development."

Mr. Achtmann is currently the Founder & Managing Director of Global Capital X. Eric is a business leader, serial entrepreneur, investor, and award-winning innovator in both large and small organizations who has systematically created billions in value. Following his time at the US Congressional Lean Aerospace Initiative and McDonnell-Douglas Phantom Works, Eric was a Defense, Aerospace & Automotive expert at McKinsey and pioneered the Firm's highly successful product development practice (DTC/DTV), raised and invested 2 pan-European combined tech and life science venture funds, and co-founded V-Nova which provides technology underlying the new global video compression standard. He proposed, architected and delivered to market the global fresh drinks vending system underpinning Coca Cola's $5.1b acquisition of Costa Coffee, having generated over 125 patents/claims in only 6 months. Further, he is a Founding Member of Meggitt PLC's Technology Advisory Board (LSE: MGGT), Senior Advisor to McKinsey, Founding Director of Celdara Medical, Director of Javelin Oncology, Expert Advisor to the European Commission, US Air Force AFWERX Mentor, and was recently credited with successfully mediating a US-Russian patent dispute involving strategic CRISPR gene-editing technology.

Eric holds an MBA in Finance from the MIT Sloan School of Management and further degrees from MIT (MS, Aero- & Astronautics); Von Karman Institute (MS, Fluid Dynamics); TU Munich (Aero- & Astronautics); and Univ. of New Hampshire (BS, Mech. Eng.).

"It is an honor to work with such an experienced, talented and proven leadership team which is uniquely qualified to serve as a key enabler for this >$50 billion global civil and defense drone market. Target Arm's patented technology facilitates the mobile launch and recovery of drones; thereby, unlocking the "last mile" of logistics, inspection, and observations for massive industries including package delivery, energy (e.g., solar, wind, oil & gas), as well as first responders and the military. Target Arm's future is very promising, and its opportunities are limitless", remarked Achtmann.

To learn more about Target Arm, visit https://www.targetarm.com.